We deliver a comprehensive, risk-based evaluation of your manufacturing, quality control, and documentation practices against current regulatory expectations (FDA, EMA, and global standards).
We provide a strategic, end-to-end framework to either build a robust Quality Management System from the ground up or modernize your existing infrastructure to meet current Good Manufacturing Practice (cGMP) standards.
We deliver an independent, forensic-grade risk assessment that bridges the critical gap between financial modelling and regulatory reality.
We deliver a disciplined, science-driven approach that goes far beyond surface-level corrections to uncover the true root causes of non-conformances and prevent their recurrence across your entire quality ecosystem.
We provide a holistic, science-based approach to designing, optimizing, or retrofitting your manufacturing and testing environments to meet current global regulatory standards (FDA, EMA, and WHO).
We provide a comprehensive, engineering-led evaluation of your controlled environments, from ISO 5 (Grade A) to ISO 8 (Grade D) classifications, ensuring that your HVAC systems deliver the precise temperature, humidity, pressure cascades, and airflow velocities required to maintain operational compliance.
We deliver a science-based, risk-driven lifecycle approach that covers the entire spectrum of cGMP expectations, from designing robust validation master plans to executing rigorous performance qualification (PQ), installation/operational qualification (IQ/OQ), and ongoing continued process verification.
We deliver a systematic, risk-based lifecycle approach that ensures your critical GxP regulated systems—including ERP, LIMS, MES, CDS, clinical trial platforms, and automated manufacturing controls—operate consistently, securely, and in full alignment with global standards such as 21 CFR Part 11, EU Annex 11, and ICH guidelines
We deliver a holistic, science-driven approach to the design, qualification, monitoring, and remediation of these essential systems against rigorous global pharmacopeial standards (USP, Ph. Eur., JP) and FDA/EMA regulatory expectations.
An indispensable frontline defence against raw material adulteration, supply disruptions, and regulatory enforcement actions.
We provide end-to-end expertise in the authoring, compilation, formatting, review, and lifecycle management of all critical regulatory dossiers, ensuring every submission meets the stringent scientific, technical, and administrative expectations of global health authorities including the FDA, EMA, MHRA, and beyond.
We deliver a comprehensive, two-pronged workforce solution that bridges immediate capacity gaps while simultaneously building long-term organizational excellence.
We provide end-to-end strategic and technical project management, guiding you from conceptual master planning and regulatory gap analysis through to operational handover and inspection-ready start-up.